A small number of people living with HIV have been cured of HIV after receiving a stem cell transplant given to treat their blood cancer (not as an HIV treatment). Those remarkable individuals prove that an HIV cure is possible—however the transplant procedure comes with many risks to offer the procedure to the many people living with HIV worldwide.
SHIELD HIV asks a practical question: What did the donor immune system actually do to clear the HIV reservoir—and can we copy that with targeted T-cell therapy?
Published cases include 13 individuals to date. They received allogeneic stem cell transplants from HLA-matched or partially matched donors, in most cases from donors carrying the rare CCR5Δ32/Δ32 mutation, which means their cells never make the receptor that HIV uses to enter. Complementary work in a non human primate macaque model of SIV lead to a cure after transplant.
No. Stem cell Transplant is used only when someone already needs it for a life-threatening blood cancer. It carries serious risks (including graft-versus-host disease, in which the donor’s immune cells attack the recipient’s own tissues) and is not a general HIV treatment.
A handful of stem cell transplants proved HIV can be cured. SHIELD HIV exists to learn how—at the level of specific donor T cells—and to turn that knowledge into a therapy that does not require a transplant.